Myasthenia Gravis and Pericarditis in a Patient with Thymoma

Myasthenia Gravis and Pericarditis

Authors

  • Ryan W. Fogg BS Thomas Jefferson University
  • Lillian C. Flashner BS Sidney Kimmel Medical College at Thomas Jefferson University
  • William J. Marte MD Einstein Medical Center
  • Rabia B. Choudry MD
  • Anishee S. Undavia MD Einstein Medical Center
  • Aparna M. Prabhu MD Einstein Medical Center

DOI:

https://doi.org/10.17161/rrnmf.v2i3.14790

Keywords:

myasthenia gravis, pericarditis, myocarditis, cardiac involvement

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Guglin, Maya, et al. “Cardiac Disease in Myasthenia Gravis: A Literature Review.” Journal of Clinical Neuromuscular Disease, vol. 4, no. 4, 2003, pp. 199–203., doi:10.1097/00131402-200306000-00006

Vats, Hemender S., et al. “Pericarditis in Myasthenia Gravis.” Cardiology in Review, vol. 12, no. 3, 2004, pp. 134–137., doi:10.1097/01.crd.0000117762.62596.8d.

Priemer, David S, et al. “Giant Cell Polymyositis and Myocarditis in a Patient With Thymoma and Myasthenia Gravis: A Postviral Autoimmune Process?” Journal of Neuropathology & Experimental Neurology, vol. 77, no. 8, 2018, pp. 661–664., doi:10.1093/jnen/nly041.

Finsterer J, Stollberger C. “Stress from Myasthenic Crisis Triggers Takotsubo (broken heart) Syndrome.” Int J Cardiol 2016; 203: 616-617.

Hofstad H, Ohm OJ, Mork SJ, et al. “Heart disease in myasthenia gravis." Acta Neurol Scand. 1984; 70:176-184.

Romi F, Skeie G, Gilhus N, Aarli J. “Striational Antibodies in Myasthenia Gravis: reactivity and possible clinical significance.” Arch Neurol 2005;62(3): 442-446.

Shivamurthy, Poojita, and Matthew W. Parker. “Cardiac Manifestations of Myasthenia Gravis: A Systematic Review.” IJC Metabolic & Endocrine, vol. 5, 2014, pp. 3–6., doi:10.1016/j.ijcme.2014.08.003.

Suzuki, Shigeaki, et al. “Three Types of Striational Antibodies in Myasthenia Gravis.” Autoimmune Diseases, vol. 2011, 2011, pp. 1–7., doi:10.4061/2011/740583.

Glennon, P. E., et al. “Fatal Giant Cell Myocarditis after Resection of Thymoma.” Heart, vol. 75, no. 5, 1996, pp. 531–532., doi:10.1136/hrt.75.5.531.

Suzuki, Shigeaki, et al. “Nivolumab-Related Myasthenia Gravis with Myositis and Myocarditis in Japan.” Neurology, vol. 89, no. 11, 2017, pp. 1127–1134., doi:10.1212/wnl.0000000000004359.

Rota, Eugenia, et al. “Concomitant Myasthenia Gravis, Myositis, Myocarditis and Polyneuropathy, Induced by Immune-Checkpoint Inhibitors: A Life–Threatening Continuum of Neuromuscular and Cardiac Toxicity.” ENeurologicalSci, vol. 14, 2019, pp. 4–5., doi:10.1016/j.ensci.2018.11.023.

So, Hayato, et al. “PD-1 Inhibitor-Associated Severe Myasthenia Gravis with Necrotizing Myopathy and Myocarditis.” Journal of the Neurological Sciences, vol. 399, 2019, pp. 97–100., doi:10.1016/j.jns.2019.02.023.

Yamamoto, Ana Maria, et al. “Anti-Titin Antibodies in Myasthenia Gravis.” Archives of Neurology, vol. 58, no. 6, 2001, p. 885., doi:10.1001/archneur.58.6.885.

Wanner, William R., et al. “Postoperative Pericarditis Following Thymectomy for Myasthenia Gravis.” Chest, vol. 83, no. 4, 1983, pp. 647–649., doi:10.1378/chest.83.4.647.

Hikosaka, Yu, et al. “Post-Irradiation Constrictive Pericarditis Following Thymoma Treatment: a Report of Two Cases.” General Thoracic and Cardiovascular Surgery, vol. 63, no. 7, 2013, pp. 413–415., doi:10.1007/s11748-013-0302-9.

Downloads

Published

2021-08-03

Issue

Section

Clinic and Case Reports

How to Cite

Fogg, R., Flashner, L., Marte, W., Choudry, R., Undavia, A., & Prabhu, A. (2021). Myasthenia Gravis and Pericarditis in a Patient with Thymoma: Myasthenia Gravis and Pericarditis. RRNMF Neuromuscular Journal, 2(3), 48-51. https://doi.org/10.17161/rrnmf.v2i3.14790